<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Kommentare zu: BASEL MAY 17 2013 &#8211; RESULTS OF A PIVOTAL PHASE III TRIAL IN WOMEN WITH HER2 POSITIVE HER2  ADVANCED BREAST CANCER SHOWED THAT AFINITOR EVEROLIMUS TABLETS IN COMBINATION WITH TRASTUZUMAB HERCEPTIN AND VINORELBINE&#8230;</title>
	<atom:link href="http://www.prepaid-prepaid.com/basel-may-17-2013-results-of-a-pivotal-phase-iii-trial-in-women-with-her2-positive-her2-advanced-breast-cancer-showed-that-afinitor-everolimus-tablets-in-combination-with-trastuzumab-herceptin-and-2013-05-17.html/feed" rel="self" type="application/rss+xml" />
	<link>http://www.prepaid-prepaid.com/basel-may-17-2013-results-of-a-pivotal-phase-iii-trial-in-women-with-her2-positive-her2-advanced-breast-cancer-showed-that-afinitor-everolimus-tablets-in-combination-with-trastuzumab-herceptin-and-2013-05-17.html?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=basel-may-17-2013-results-of-a-pivotal-phase-iii-trial-in-women-with-her2-positive-her2-advanced-breast-cancer-showed-that-afinitor-everolimus-tablets-in-combination-with-trastuzumab-herceptin-and</link>
	<description></description>
	<lastBuildDate></lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.5.1</generator>
</channel>
</rss>
